Using a test based on parent of origin specific DNA methylation at the D15S63 (PW71) locus, we studied 385 patients (aged 1 to 36 years) for diagnostic confirmation of Prader-Willi syndrome (PWS) and 65 infants (aged 0 to 12 months) with severe hypotonia of unknown cause. 
marker PW71 (D15S63),9 and the gene for the small nuclear ribonucleoprotein N (SNRPN). ' At the D 15S63 locus, at least one HpaII site and one CfoI site are methylated on the maternal chromosome, but unmethylated on the paternal chromosome.9"' Based on these differences, we have devised a simple diagnostic test for PWS. Genomic DNA is digested with Hind III + HpaII or BglII + CfoI and hybridised with PW7 1. Patients with PWS typically lack the paternal PW71 band.'2 The test detects deletions, uniparental disomies, and imprinting mutations, but does not distinguish between these aberrations.679 Here we describe the results obtained in 450 patients suspected of having Prader-Willi syndrome.
Patients and methods

PATIENTS
From 1 June 1992 to 31 May 1994, we studied 450 patients (256 females and 194 males). The ages ranged from 0 to 36 years. A total of 58/ 450 patients was examined personally by GG-K and EP using the well defined diagnostic criteria for PWS"2 and 392 blood samples were sent to us from outside. Referring clinicians were asked to enter the clinical, historical, and anthropometric data into a questionnaire, which was developed by us patients. This is also obvious from the data provided by the questionnaires (table 3) . Although these data could not be verified by personal examination of the patients, they indicate that most of the patients with a normal methylation pattern lack major diagnostic criteria,'2 such as neonatal hypotonia, feeding problems, characteristic facies, and hypogenitalism.
In some of the patients examined personally we were able to make a differential diagnosis. Our major differential diagnoses included Cohen syndrome, pseudohypoparathyroidism, Alstr0m syndrome, and Bardet-Biedl syndrome. A very interesting differential diagnosis was made in patient M3961. The Ohdo-like blepharophimosis syndrome shows a number of overlapping features with PWS in the neonatal period, such as muscular hypotonia, feeding problems, and scrotal hypoplasia, but the craniofacial abnormalities are clearly distinct.'6 Less experienced clinicians may not be able to differentiate this condition from PWS by clinical examination alone. We are well aware of the fact that the list of differential diagnoses is far from being complete because it is only based on a small number ofpatients. Numerous differential diagnoses are possible, expecially in newborns presenting with hypotonia and feeding problems.
Among 65 young infants with severe hypotonia of unknown cause, we have found 29 patients (45%) who tested positive for PWS. The high frequency of positive findings in this group of patients was unexpected and is most likely because of ascertainment bias. For accurate assessment of the frequency of PWS among hypotonic newborns, we have started a two year prospective study in which all children born in two large German cities (annual birth rate 6000) will be clinically examined,, and hypotonic infants will be tested for PWS. Despite the ascertainment bias in our present study, PWS is a significant cause of hypotonia in early infancy and we suggest performing the PW71 methylation test in such cases. This may help to prevent more invasive diagnostic procedures and ensure early support for the patient.
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